Prevalence and Risk Factors of Women Mental Health Disorders

Prevalence and Risk Factors of Women Mental Health Disorders in Assiut Governorate

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. On the other hand, Depressive disorder in women mainly occurs during the first year after childbirth. It takes many forms according to the onset, severity, and duration of the symptoms including; Postpartum blues (PPB), Postpartum depression (PPD), and Postpartum psychosis (PPP). Lack of access to mental health services during the perinatal period is a significant public health concern that may worse outcome.

So, we aimed to study prevalence of women mental health in Assiut governorate and evaluate possible risk factor for it

Study Overview

• Status: Not yet recruiting
• Conditions: Psychiatric Problem; Wolman Disease
• Intervention / Treatment: Behavioral: Sociodemographic variables; Behavioral: Family affluence scale (FAS); Behavioral: Edinburgh postnatal depression scale (EPDS); Behavioral: Symptom Checklist 90 "SCL 90":

• Study Type: Observational
• Enrollment (Anticipated): 200

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

• Sampling Method: Probability Sample

Study Population

This is study will take part in the Assiut government primary health centres in community

Description

Inclusion Criteria:

• age 18 years -50 years.
• No previous history of psychiatric, neurological or medical disease

Exclusion Criteria:

• intelligence equation less than 80
• have history of psychiatric, neurological or medical disease

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Only
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Perinatal group; females who are pregnancy	Behavioral: Sociodemographic variables; age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.; Behavioral: Family affluence scale (FAS); a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.; Behavioral: Edinburgh postnatal depression scale (EPDS); s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed; Behavioral: Symptom Checklist 90 "SCL 90": is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed
postpartum group; female who get delivery(from day 1 up to 1 year)	Behavioral: Sociodemographic variables; age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.; Behavioral: Family affluence scale (FAS); a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.; Behavioral: Edinburgh postnatal depression scale (EPDS); s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed; Behavioral: Symptom Checklist 90 "SCL 90": is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
measure the prevalence of DSM 5 psychiatric disorders in perinatal and postnatal	through study completion, an average of 1 year
measure of risk factor of DSM 5 psychiatric disorders in perinatal and postnatal	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: Assiut University

Publications and helpful links

General Publications

• Sambrook Smith M, Lawrence V, Sadler E, Easter A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta-synthesis of qualitative studies in the UK. BMJ Open. 2019 Jan 24;9(1):e024803. doi: 10.1136/bmjopen-2018-024803.
• Sheffield KM, Woods-Giscombe CL. Efficacy, Feasibility, and Acceptability of Perinatal Yoga on Women's Mental Health and Well-Being: A Systematic Literature Review. J Holist Nurs. 2016 Mar;34(1):64-79. doi: 10.1177/0898010115577976. Epub 2015 Apr 20.
• Sharma V, Burt VK. DSM-V: modifying the postpartum-onset specifier to include hypomania. Arch Womens Ment Health. 2011 Feb;14(1):67-9. doi: 10.1007/s00737-010-0182-2. Epub 2010 Sep 25.

Study record dates

Study Major Dates

• Study Start (Anticipated): March 1, 2021
• Primary Completion (Anticipated): September 1, 2022
• Study Completion (Anticipated): September 1, 2023

Study Registration Dates

• First Submitted: March 8, 2021
• First Submitted That Met QC Criteria: March 8, 2021
• First Posted (Actual): March 11, 2021

Study Record Updates

• Last Update Posted (Actual): March 11, 2021
• Last Update Submitted That Met QC Criteria: March 8, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: mental health; women
• Additional Relevant MeSH Terms: Metabolic Diseases; Infant, Newborn, Diseases; Genetic Diseases, Inborn; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Lipid Metabolism Disorders; Lipidoses; Lipid Metabolism, Inborn Errors; Cholesterol Ester Storage Disease; Mental Disorders; Wolman Disease
• Other Study ID Numbers: women mental health disorders

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No